Please Wait...

Elizabeth Edwards

Translation skills

Main profile

Elizabeth Edwards
President, Global Clinical Research

Elizabeth Edwards, President, Global Clinical Research and a member of Bioclinica’s executive management team, leads a multi-faceted organization comprising the Bioclinica Research Network with a geographic footprint spanning the U.S., Europe, Latin America and Asia, as well as the Company’s Patient Recruitment and Post-Approval Research business. As an accomplished executive in end-to-end pharmaceutical research and development, Elizabeth is well-equipped for the role. She has extensive scientific and clinical experience and has contributed substantially to numerous drug approvals within Oncology, Musculoskeletal, Gastroenterology, Neurology, Immunology, and other therapeutic areas. Prior to joining Bioclinica, Elizabeth was with global contract research organization Chiltern International where she played a key role in advancing the clinical research of oncology biopharmaceutical and medical device manufacturers. While there, as senior vice president of Oncology for project management and clinical operations in Europe and North America, she coordinated and led a 1,000+ member team, including Oncology directors of project management, project managers, clinical trial leaders, and clinical trial associates spread across 47 countries. At Chiltern she achieved significant growth and operational excellence for North America and Europe. Earlier, Elizabeth was with Novella Clinical where she was executive vice president of global operations, and managing director of Europe during which time she led an international team of clinical staff and increased sustainable global field productivity by 30 percent.  Prior to this, Elizabeth founded and managed a successful private clinical development consulting firm, Edwards Pharmaceutical Research, where she managed successful drug development for biotech companies by orchestrating new drug filing strategies and clinical development processes. Preceding this, Elizabeth was senior director in clinical development for Inspire Pharmaceuticals, primarily responsible for delivery of their Cystic Fibrosis programs.  Early in her career, Elizabeth was a clinical research scientist assigned to GSK studies in the areas of Oncology, Rheumatology, Immunology, Gastroenterology, Pain and Urology. Elizabeth has a Bachelor’s degree in Pre-Medicine, Psychology from the University of Virginia.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil… https://t.co/77NOME2Dj7
bioclinica (21 hours ago)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace… https://t.co/f9vtRpsbMW
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c… https://t.co/PAdROjo7tE
bioclinica (Yesterday)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg https://t.co/cAewLypUY7
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus https://t.co/jgwaqxfiXl #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '… https://t.co/NxauNywq23
bioclinica (6 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen